EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel method to quantify TSG‐6 protein levels in synovial fluid from osteoarthritis patients

Jenny L. Scott, Yan Dong, Junying Yin, Rebecca J. Dodd, Nikolaos Kouvatsos, Sheona P. Drummond, Sanjay Anand, Leela C. Biant, Caroline M. Milner, Anthony J. Day

Proteoglycan Research · 2024

DOI: 10.1002/pgr2.70003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proteoglycan Research, 2024. Verfasst von Jenny L. Scott und 9 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TSG‐6, the protein product of Tumor Necrosis Factor‐stimulated gene‐6, is a potential biomarker of disease activity/progression in osteoarthritis (OA). By ELISA, TSG‐6 is elevated in synovial fluid (SF) from OA patients and its catalytic activity, for the covalent transfer of inter‐α‐inhibitor heavy chains onto hyaluronan (HA), is reported to correlate with progression to total knee replacement. Here, quantitative western blot (qWB) analysis, following sequential digestion with hyaluronidase and chondroitinase enzymes, was developed for the accurate determination of TSG‐6 levels in SFs. qWB analysis of 125 OA SFs yielded values of 1.0–45.2 μg/mL (median: 3.9 μg/mL), 100–1000‐fold higher than those previously reported; TSG‐6 concentration was positively correlated with age and pain/outcome scores in male patients. The values determined, by ELISA or a heavy chain transfer activity assay, following the same digestion conditions (in 23 SFs), were both ≥10‐fold lower. Apparent TSG‐6 catalytic activity was significantly affected by the concentration of HA present in SF or added exogenously. Thus, the interactions of TSG‐6 with components of OA SF prevent accurate determination of its concentration/activity when using existing assays. However, the quantitative western blot method developed here appears more suitable for further evaluation of the utility of TSG‐6 as a biomarker in OA.

Förderung

  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Scott, J. L., Dong, Y., Yin, J., Dodd, R. J., Kouvatsos, N., Drummond, S. P., Anand, S., Biant, L. C., Milner, C. M., & Day, A. J. (2024). A novel method to quantify TSG‐6 protein levels in synovial fluid from osteoarthritis patients. Proteoglycan Research. https://doi.org/10.1002/pgr2.70003

Vancouver

Scott JL, Dong Y, Yin J, Dodd RJ, Kouvatsos N, Drummond SP, et al. A novel method to quantify TSG‐6 protein levels in synovial fluid from osteoarthritis patients. Proteoglycan Research. 2024. doi:10.1002/pgr2.70003

BibTeX
@article{Scott2024,
  author = {Scott, Jenny L. and Dong, Yan and Yin, Junying and Dodd, Rebecca J. and Kouvatsos, Nikolaos and Drummond, Sheona P. and Anand, Sanjay and Biant, Leela C. and Milner, Caroline M. and Day, Anthony J.},
  title = {A novel method to quantify TSG‐6 protein levels in synovial fluid from osteoarthritis patients},
  journal = {Proteoglycan Research},
  year = {2024},
  doi = {10.1002/pgr2.70003}
}
Kostenlos starten →